Sort
16,300 grants matching “fatty liver disease”
Project 4: The Role of Fatty Acid Synthase in Colorectal Cancer
$306,129Yekaterina Zaytseva · University Of Kentucky · P20 · FY2019 · GM
Project 4: The Role of Fatty Acid Synthase in Colorectal Cancer
$306,129Yekaterina Zaytseva · University Of Kentucky · P20 · FY2020 · GM
S6 Kinase, Aging and Age-related Disease
$306,120Brian K Kennedy · University Of Washington · R01 · FY2009 · AG
Role of heat shock transcription factor HSF1 in tumoroginesis
$306,113Nahid F Mivechi · Augusta University · R01 · FY2014 · CA
FUNCTIONAL STUDIES OF FAAH
$306,010Benjamin F Cravatt · Scripps Research Institute, The · P01 · FY2007 · DA
Egr1: A candidate molecular target for treating ALD.
$306,000Case Western Reserve University · R01 · FY2004 · AA
Egr1: A candidate molecular target for treating ALD.
$306,000Case Western Reserve University · R01 · FY2005 · AA
Hepatokine Control of Metabolic Crosstalk and Insulin Resistance
$306,000Mengwei Zang · University Of Texas Hlth Science Center · R01 · FY2019 · DK
Nutrient-sensing GHS-R in macrophage reprogramming and inflamm-aging
$305,987Yuxiang Sun · Texas A&M Agrilife Research · R01 · FY2022 · AG
Molecular Mechanisms by which TNFalpha Modulates Fibrosis
$305,910David A Brenner · University Of California, San Diego · R01 · FY2010 · GM
AI-Based Image Phenotyping of Early ADPKD
$305,844Martin R Prince · Weill Medical Coll Of Cornell Univ · U54 · FY2025 · DK
Genetics of Nonalcoholic Fatty Liver Disease (NAFLD)
$305,807Sandra Karolyn Erickson · Northern California Institute/Res/Edu · R01 · FY2010 · DK
Novel targets that are deregulated by loss of PTEN
$305,803Deborah Johnson · University Of Southern California · R01 · FY2012 · CA
Novel Roles for Lysophospholippids in Eukaryotic Membrane Biogenesis and Turnover
$305,791Dennis R Voelker · National Jewish Health · R01 · FY2011 · GM
Nutrient-sensing GHS-R in macrophage reprogramming and inflamm-aging
$305,758Yuxiang Sun · Texas A&M Agrilife Research · R01 · FY2023 · AG
Apolipoprotein CIII inhibition in partial lipodystrophy
$305,663Rebecca Brown · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2017 · DK
CNS EFFECTS OF ADIPOKINES ON METABOLISM
$305,540Rexford S Ahima · University Of Pennsylvania · P01 · FY2007 · DK
Pediatric Adverse Drug Reactions in NASH
$305,519Nathan J Cherrington · University Of Arizona · R01 · FY2013 · HD
Microbiome as therapeutic target in alcoholic hepatitis
$305,515Bernd G. Schnabl · University Of California, San Diego · U01 · FY2019 · AA
Project 3: A Novel Simultaneous Multiparametric MRI Approach for the Quantitative Assessment of Non-alcoholic Fatty Liver Disease
$305,433Christoph Alexander Rettenmeier · University Of Hawaii At Manoa · P20 · FY2022 · GM
Nutrient-sensing GHS-R in macrophage reprogramming and inflamm-aging
$305,429Yuxiang Sun · Texas A&M Agrilife Research · R01 · FY2020 · AG
De Novo Lipogenesis and Metabolic Disease
$305,368Clay F. Semenkovich · Washington University · R01 · FY2008 · DK
De Novo Lipogenesis and Metabolic Disease
$305,368Clay F. Semenkovich · Washington University · R01 · FY2009 · DK
Dysregulation of Glucose Homeostasis in Aging
$305,313Nir J Barzilai · Albert Einstein College Of Medicine · R01 · FY2009 · AG
Regulation of the Unfolded Protein Response by eIF2 alpha phosphatases
$305,216Douglas Conrad Weiser · University Of The Pacific-Stockton · R15 · FY2017 · GM